The Planning Shop International has been acquired by Adelphi Worldwide
September 2014 — The founding shareholders of The Planning Shop International (TPSI) have sold the company to Adelphi Worldwide, part of the Omnicom Group. Financial details have not been disclosed.
TPSI is a specialist pharmaceutical brand strategy agency. The company provides a unique consumer-based insight into every step of the product life cycle.
Adelphi Worldwide, part of the Omnicom Group, is engaged in pharmaceutical consultancy and service provision. Adelphi’s offer spans the lifecycle of pharmaceutical development, with comprehensive services in strategic product development consultancy, health economics and outcomes research, real world disease understanding, marketing research, medical communications and post-meeting brand support services.
Our role in the transaction
Oaklins Cavendish, based in the UK, advised the seller in this transaction.
Talk to the deal team
Related deals
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn more